# Tigecycline

## Tygacil inj 50mg

| 藥物代碼           | ITYG                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Treatment of complicated skin & skin structure infections, complicated intra-abdominal infections & community-acquired pneumonia caused by susceptible microorganisms sensitive to tigecycline.                                                                                                                                                                                                                                                                                                              |
| 副作用             | Abdominal pain, abscess, asthenia, back pain, fever, headache, infection, pain; HTN, hypotension, phlebitis; constipation, diarrhea, dyspepsia, nausea, vomiting; anemia, leukocytosis, thrombocythemia; increased alkaline phosphatase/amylase/BUN/lactic dehydrogenase/SGOT/SGPT, bilirubinemia, abnormal healing, hyperglycemia, hypokalemia, hypoproteinemia, peripheral edema; dizziness, insomnia; increased cough, dyspnea, pulmonary physical finding; pruritus, rash, sweating; inj site reactions. |
| 禁忌               | Hypersensitivity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 藥物保存方式       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 用法用量           | Adult >=18 years Initially, 100 mg by IV infusion over approx 30-60 mins once, followed by 50 mg 12 hrly. Complicated skin and skin structure infections or complicated intra-abdominal infections Duration of treatment: 5-14 days. Community-acquired pneumonia 7-14 days.                                                                                                                                                                                                                                 |
| 肝功能異常         | 需 調 整 劑 量  Child-Pugh A and B: No adjustment necessary;Child-Pugh C:Initial dose, 100 mg IV once, followed by 25 mg IV every 12 hours                                                                                                                                                                                                                                                                                                                                                                   |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 懷孕用藥危分級     | 儘量避免                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 孕期用藥建議       | Human data suggest risk in 2nd and 3rd trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 注射劑給藥建議途徑 | IVD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 乾粉稀釋液         | 1.IVD: 5.3 mL N/S或D5W或L/R，調配成藥液濃度10mg/mL，只需取出5mL.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 輸注點滴液         | 【D5W】 可選  【L/R】 可選  【N/S】 可選                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| IVD 用法建議       | 給藥濃度≦ 1mg/mL,建議以 >30 ~ 60分鐘緩慢滴注                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 注意事項           | 1. 稀釋於小瓶內的溶液室溫最多擺放6小時，稀釋好的輸注溶液室溫下最多擺放24小時 (包含原先在小瓶內的6小時)。因此，若使用方式為25mg Q12H，建議將小瓶內剩餘的藥液置於冰箱冷藏 (最多48小時)，下次給藥前再加於輸注溶液。 2. 藥液若變色則不可使用。(調配好的藥液應呈黃色或橙色) 3. Tygacil給藥時必須使用專用的輸注管路，或使用Y型輸注管路，以便與其他輸注藥液區別。 4. 監測體溫、CBC與感染症狀變化。 5. 監測肝功能。                                                                                                  |

